ESR1 and breast cancer: We previously reported that pure AEs can be distinguished from SERMs by their capacity to induce rapid modification of ERα by SUMO1/2/3 in receptor-positive BC cell lines and in transfected ER-negative cell lines following pure AE treatment [24].